INVESTOR RELATIONS

Latest News

Sign Up for E-Mail Alerts


By submitting this form, you are consenting to receive marketing emails from: Phoenix Life Sciences International Limited, 3000 Lawrence Street, Denver, CO, 80205, http://www.phoenixlife.co. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

OVERVIEW

Phoenix Life Sciences International Limited is an adaptive botanical healthcare solutions company. Our business is to advance research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. We strive to creating partnerships and integrate these programs for human health into communities worldwide as part of our Global Health Initiative.

BE A PART OF THE GLOBAL HEALTH REVOLUTION

ABOUT

Phoenix Life Sciences International Limited
OTC: PLSI

Born from the desire to improve global health, Phoenix Life Sciences International Limited was created to find alternative treatments to many of the major health concerns of today. The Founder, Martin Tindall, was driven to find alternative solutions after watching his father die from chemotherapy-based blood poisoning. Phoenix truly believes in the ability to create a future where the human body can repair, restore and rejuvenate itself.

Like many of us, intuitively knowing that there was a safer and more nature-based solution, the journey lead him to medical cannabis and the mission to create a global platform for the reintroduction of medical cannabis products into the healthcare mainstream.

With that in mind, Phoenix has set up its core business to enable everyone a level of healthcare access, as everyone deserves the opportunity to live a healthy life.

Phoenix is dedicated to sharing its global vision and will continue to share its strategy to see its overall goal of making a difference for everyone.

Phoenix produces and distribute products around the globe designed to advance research and integrate programs of products that target and treat; diabetes, pain, cancers, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. We provide a patient-centric alternative to the low efficacy and the high side effects of conventional pharmaceutical drugs.

Phoenix Life Sciences International Limited uses organically-produced cannabis plants, extracts the purist of active ingredients and botanicals, and then encapsulates them for maximum bioavailability and efficacy.

Our aim is to give doctors and their patients an easy to consume, easy to manage, accurately dosed natural healthcare solution. Phoenix Life Sciences International Limited’s target goal is to build production to service over 2.5 million patients over the next 5 years.

Rapid-Growth Market

Solid Fiscal Strategy

World Class Talent

Contacts

Public Relations Contact:

CMW Media
Kathryn Reinhardt, 858-264-6600
kathryn@cmwmedia.com
www.cmwmedia.com

Investor Relations Contact:

+1.888.717.5655

investor.relations@phoenixlife.co

Law Firms:

Transfer Agent Contact:

Clear Trust
16540 Pointe Village Dr, Suite 205 Lutz, Florida 33558
Phone 813.235.4490
Fax 813.388.4549

1200-750 W. Pender Street
Vancouver, British Columbia
Canada, V6C 2T8
EMAIL:info@mortonlaw.ca

PH:604-681-1194
FAX:604-681-9652

Levels 5 & 9, Corporate Centre One,
2 Corporate Court,
Bundall, QLD, 4217
Australia

Phone: (07) 5592 1921
Fax: (07) 5592 1222

Email: enquiries@ramsdenlaw.com.au

2nd Floor, Raffea House, Lini Highway
Port Vila, Vanuatu

Tel: (+678) 22067
Fax: (+678) 23710

DENVER OFFICE
The Equitable Building
730 17th Street, Suite 420
Denver, Colorado 80202

PHONE 303.674.7000
FAX 303.382.4685